IQVIA HOLDINGS INC. Interest Expense
IQVIA HOLDINGS INC. (IQV) reported Interest Expense of $192.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2026-05-05
- IQVIA HOLDINGS INC. interest expense for the quarter ending 2026-03-31 was $192.00M, a 16.36% increase year-over-year.
- IQVIA HOLDINGS INC. interest expense for the quarter ending 2025-12-31 was $193.00M, a 12.87% increase year-over-year.
- IQVIA HOLDINGS INC. interest expense for the quarter ending 2025-09-30 was $189.00M, a 11.18% increase year-over-year.
- IQVIA HOLDINGS INC. interest expense for the quarter ending 2025-06-30 was $182.00M, a 11.66% increase year-over-year.
- IQVIA HOLDINGS INC. interest expense for fiscal 2025 was $729.00M, a 8.81% increase from fiscal 2024.
- IQVIA HOLDINGS INC. interest expense for fiscal 2024 was $670.00M, a 0.30% decline from fiscal 2023.
- IQVIA HOLDINGS INC. interest expense for fiscal 2023 was $672.00M, a 61.54% increase from fiscal 2022.
- IQVIA HOLDINGS INC. interest expense for fiscal 2022 was $416.00M, a 10.93% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $192.00M 10-Q · filed 2026-05-05 | $385.00M derived: sum of 2 quarters · filed 2026-05-05 | $574.00M derived: sum of 3 quarters · filed 2026-05-05 | $756.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-12-31 | $193.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $382.00M derived: sum of 2 quarters · filed 2026-02-17 | $564.00M derived: sum of 3 quarters · filed 2026-02-17 | $729.00M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $189.00M 10-Q · filed 2025-10-28 | $371.00M derived: sum of 2 quarters · filed 2025-10-28 | $536.00M 10-Q · filed 2025-10-28 | $707.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-06-30 | $182.00M 10-Q · filed 2025-07-22 | $347.00M 10-Q · filed 2025-07-22 | $518.00M derived: sum of 3 quarters · filed 2026-05-05 | $688.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2025-03-31 | $165.00M 10-Q · filed 2026-05-05 | $336.00M derived: sum of 2 quarters · filed 2026-05-05 | $506.00M derived: sum of 3 quarters · filed 2026-05-05 | $669.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $171.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $341.00M derived: sum of 2 quarters · filed 2026-02-17 | $504.00M derived: sum of 3 quarters · filed 2026-02-17 | $670.00M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $170.00M 10-Q · filed 2025-10-28 | $333.00M derived: sum of 2 quarters · filed 2025-10-28 | $499.00M 10-Q · filed 2025-10-28 | $680.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $163.00M 10-Q · filed 2025-07-22 | $329.00M 10-Q · filed 2025-07-22 | $510.00M derived: sum of 3 quarters · filed 2026-02-17 | $691.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $166.00M 10-Q · filed 2025-05-06 | $347.00M derived: sum of 2 quarters · filed 2026-02-17 | $528.00M derived: sum of 3 quarters · filed 2026-02-17 | $697.00M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $181.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $362.00M derived: sum of 2 quarters · filed 2026-02-17 | $531.00M derived: sum of 3 quarters · filed 2026-02-17 | $672.00M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $181.00M 10-Q · filed 2024-10-31 | $350.00M derived: sum of 2 quarters · filed 2024-10-31 | $491.00M 10-Q · filed 2024-10-31 | $619.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $169.00M 10-Q · filed 2024-07-22 | $310.00M 10-Q · filed 2024-07-22 | $438.00M derived: sum of 3 quarters · filed 2025-02-13 | $546.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $141.00M 10-Q · filed 2024-05-02 | $269.00M derived: sum of 2 quarters · filed 2025-02-13 | $377.00M derived: sum of 3 quarters · filed 2025-02-13 | $471.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $128.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $236.00M derived: sum of 2 quarters · filed 2025-02-13 | $330.00M derived: sum of 3 quarters · filed 2025-02-13 | $416.00M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $108.00M 10-Q · filed 2023-11-01 | $202.00M derived: sum of 2 quarters · filed 2023-11-01 | $288.00M 10-Q · filed 2023-11-01 | $378.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $94.00M 10-Q · filed 2023-08-01 | $180.00M 10-Q · filed 2023-08-01 | $270.00M derived: sum of 3 quarters · filed 2024-02-15 | $362.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $86.00M 10-Q · filed 2023-04-28 | $176.00M derived: sum of 2 quarters · filed 2024-02-15 | $268.00M derived: sum of 3 quarters · filed 2024-02-15 | $362.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $182.00M derived: sum of 2 quarters · filed 2024-02-15 | $276.00M derived: sum of 3 quarters · filed 2024-02-15 | $375.00M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $92.00M 10-Q · filed 2022-10-27 | $186.00M derived: sum of 2 quarters · filed 2022-10-27 | $285.00M 10-Q · filed 2022-10-27 | $387.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $94.00M 10-Q · filed 2022-07-22 | $193.00M 10-Q · filed 2022-07-22 | $295.00M derived: sum of 3 quarters · filed 2023-02-15 | $395.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $99.00M 10-Q · filed 2022-04-28 | $201.00M derived: sum of 2 quarters · filed 2023-02-15 | $301.00M derived: sum of 3 quarters · filed 2023-02-15 | $409.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $102.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $202.00M derived: sum of 2 quarters · filed 2023-02-15 | $310.00M derived: sum of 3 quarters · filed 2023-02-15 | $416.00M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $100.00M 10-Q · filed 2021-10-22 | $208.00M derived: sum of 2 quarters · filed 2021-10-22 | $314.00M 10-Q · filed 2021-10-22 | $423.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | $108.00M 10-Q · filed 2021-07-28 | $214.00M 10-Q · filed 2021-07-28 | $323.00M derived: sum of 3 quarters · filed 2022-02-16 | $437.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $106.00M 10-Q · filed 2021-04-23 | $215.00M derived: sum of 2 quarters · filed 2022-02-16 | $329.00M derived: sum of 3 quarters · filed 2022-02-16 | $443.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | $109.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $223.00M derived: sum of 2 quarters · filed 2022-02-16 | $337.00M derived: sum of 3 quarters · filed 2022-02-16 | $447.00M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $114.00M 10-Q · filed 2020-10-22 | $228.00M derived: sum of 2 quarters · filed 2020-10-22 | $338.00M 10-Q · filed 2020-10-22 | $444.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $114.00M 10-Q · filed 2020-07-23 | $224.00M 10-Q · filed 2020-07-23 | $330.00M derived: sum of 3 quarters · filed 2021-02-12 | $435.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $110.00M 10-Q · filed 2020-04-30 | $216.00M derived: sum of 2 quarters · filed 2021-02-12 | $321.00M derived: sum of 3 quarters · filed 2021-02-12 | $428.00M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $106.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $211.00M derived: sum of 2 quarters · filed 2021-02-12 | $318.00M derived: sum of 3 quarters · filed 2021-02-12 | $414.00M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $105.00M 10-Q · filed 2019-11-01 | $212.00M derived: sum of 2 quarters · filed 2019-11-01 | $308.00M 10-Q · filed 2019-11-01 | $405.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-06-30 | $107.00M 10-Q · filed 2019-07-24 | $203.00M 10-Q · filed 2019-07-24 | $300.00M derived: sum of 3 quarters · filed 2020-02-18 | $393.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-03-31 | $96.00M 10-Q · filed 2019-05-02 | $193.00M derived: sum of 2 quarters · filed 2020-02-18 | $286.00M derived: sum of 3 quarters · filed 2020-02-18 | $367.00M derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | $97.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $190.00M derived: sum of 2 quarters · filed 2020-02-18 | $271.00M derived: sum of 3 quarters · filed 2020-02-18 | $346.00M 10-K · filed 2020-02-18 | ||||
| 2017-09-30 | $93.00M 10-Q · filed 2018-10-25 | $174.00M derived: sum of 2 quarters · filed 2018-10-25 | $249.00M 10-Q · filed 2018-10-25 | $320.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-06-30 | $81.00M 10-Q · filed 2018-07-27 | $156.00M 10-Q · filed 2018-07-27 | $227.00M derived: sum of 3 quarters · filed 2019-02-19 | $252.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-03-31 | $75.00M 10-Q · filed 2018-05-04 | $146.00M derived: sum of 2 quarters · filed 2019-02-19 | $171.00M derived: sum of 3 quarters · filed 2019-02-19 | $193.00M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2016-12-31 | $71.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $96.00M derived: sum of 2 quarters · filed 2019-02-19 | $118.00M derived: sum of 3 quarters · filed 2019-02-19 | $144.00M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | $25.00M 10-Q · filed 2017-10-27 | $24.50M 10-Q · filed 2016-11-03 | $47.00M derived: sum of 2 quarters · filed 2017-10-27 | $73.00M 10-Q · filed 2017-10-27 | $72.95M 10-Q · filed 2016-11-03 | $97.74M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $22.00M 10-Q · filed 2017-08-04 | $22.48M 10-Q · filed 2016-07-27 | $48.00M 10-Q · filed 2017-08-04 | $48.44M 10-Q · filed 2016-07-27 | $72.74M derived: sum of 3 quarters · filed 2018-02-16 | $98.17M derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $26.00M 10-Q · filed 2017-05-08 | $25.96M 10-Q · filed 2016-05-03 | $50.74M derived: sum of 2 quarters · filed 2018-02-16 | $76.17M derived: sum of 3 quarters · filed 2018-02-16 | $101.66M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $24.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $50.17M derived: sum of 2 quarters · filed 2018-02-16 | $75.66M derived: sum of 3 quarters · filed 2018-02-16 | $101.00M 10-K · filed 2018-02-16 | $101.79M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $25.43M 10-Q · filed 2016-11-03 | $50.92M derived: sum of 2 quarters · filed 2016-11-03 | $76.26M 10-Q · filed 2016-11-03 | $102.70M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $25.49M 10-Q · filed 2016-07-27 | $50.83M 10-Q · filed 2016-07-27 | $77.28M derived: sum of 3 quarters · filed 2017-02-16 | $102.33M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $25.34M 10-Q · filed 2016-05-03 | $51.79M derived: sum of 2 quarters · filed 2017-02-16 | $76.84M derived: sum of 3 quarters · filed 2017-02-16 | $101.64M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $26.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $51.50M derived: sum of 2 quarters · filed 2017-02-16 | $76.30M derived: sum of 3 quarters · filed 2017-02-16 | $101.00M 10-K · filed 2017-02-16 | -$100.59M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $25.05M 10-Q · filed 2015-10-28 | $49.85M derived: sum of 2 quarters · filed 2015-10-28 | $74.55M 10-Q · filed 2015-10-28 | $101.38M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $24.80M 10-Q · filed 2015-07-29 | $49.50M 10-Q · filed 2015-07-29 | $76.33M derived: sum of 3 quarters · filed 2016-02-11 | $105.08M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $24.70M 10-Q · filed 2015-04-29 | $51.53M derived: sum of 2 quarters · filed 2016-02-11 | $80.28M derived: sum of 3 quarters · filed 2016-02-11 | $112.17M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $26.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $55.58M derived: sum of 2 quarters · filed 2016-02-11 | $87.47M derived: sum of 3 quarters · filed 2016-02-11 | $123.51M 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | $28.76M 10-Q · filed 2014-10-30 | $60.64M derived: sum of 2 quarters · filed 2014-10-30 | $96.68M 10-Q · filed 2014-10-30 | -$133.68M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $31.88M 10-Q · filed 2014-07-31 | $67.93M 10-Q · filed 2014-07-31 | -$162.43M derived: sum of 3 quarters · filed 2015-02-12 | -$128.92M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $36.04M 10-Q · filed 2014-05-01 | -$194.32M derived: sum of 2 quarters · filed 2015-02-12 | -$160.80M derived: sum of 3 quarters · filed 2015-02-12 | -$127.67M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | -$230.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$196.85M derived: sum of 2 quarters · filed 2015-02-12 | -$163.72M derived: sum of 3 quarters · filed 2015-02-12 | -$134.37M 10-K · filed 2015-02-12 | $134.37M 10-K · filed 2014-02-13 | |||
| 2012-09-30 | $33.51M 10-Q · filed 2013-10-31 | $66.64M derived: sum of 2 quarters · filed 2013-10-31 | $95.99M 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $33.13M 10-Q · filed 2013-08-01 | $62.48M 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | $29.34M 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | $109.06M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |